A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NCT02655016 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
733
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tesaro, Inc.

Collaborators